{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:29:11Z","timestamp":1769182151367,"version":"3.49.0"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Primary aldosteronism (PA) is the most common cause of endocrine hypertension. The prevalence of hypertension is higher in patients with diabetes mellitus-2 (DM-2). Following the limited existing data, we prospectively investigated the prevalence of aldosterone excess either as autonomous secretion (PA) or as a hyper-response to stress in hypertensive patients with DM-2 (HDM-2). A total of 137 HDM-2 patients and 61 non-diabetics with essential hypertension who served as controls (EH-C) underwent a combined, overnight diagnostic test, the Dexamethasone\u2013captopril\u2013valsartan test (DCVT) used for the diagnosis of PA and an ultralow dose (0.3 \u03bcg) ACTH stimulation test to identify an exaggerated aldosterone response to ACTH stimulation. Twenty-three normotensive individuals served as controls (NC) to define the normal response of aldosterone (ALD) and aldosterone-to-renin ratio (ARR) to the ultralow dose ACTH test. Using post-DCVTALD and ARR from the EH-C, and post-ACTH peak ALD and ARR from the NC, 47 (34.3%) HDM-2 patients were found to have PA, whereas 6 (10.4%) HDM-2 patients without PA (DCVT-negative) exhibited an exaggerated aldosterone response to stress\u2014a prevalence much higher than ever reported. Treatment with mineralocorticoid receptor antagonists (MRAs) induced a significant and permanent reduction of BP in all HDM-2 patients. Early diagnosis and targeted treatment of PA is crucial to prevent any aggravating effect on chronic diabetic complications.<\/jats:p>","DOI":"10.3390\/biomedicines10092308","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T22:12:43Z","timestamp":1663539163000},"page":"2308","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-6572","authenticated-orcid":false,"given":"Ernestini","family":"Tyfoxylou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-2351","authenticated-orcid":false,"given":"Nick","family":"Voulgaris","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"},{"name":"Department of Endocrinology, Athens Naval and Veterans Hospital, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7570-4358","authenticated-orcid":false,"given":"Chris","family":"Gravvanis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"},{"name":"Department of Endocrinology, 251 Hellenic Air Force & VA General Hospital, 11525 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Vlachou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-7797","authenticated-orcid":false,"given":"Labrini","family":"Papanastasiou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Tentolouris","sequence":"additional","affiliation":[{"name":"Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-2297","authenticated-orcid":false,"given":"Eva","family":"Kassi","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[{"name":"Endocrine Unit, 1st Department of Propaedeutic Medicine, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-5264","authenticated-orcid":false,"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[{"name":"University Research Institute of Maternal and Child Health and Precision Medicine and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Piaditis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center, \u201cG. Gennimatas\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/HYPERTENSIONAHA.111.00612","article-title":"Diabetes mellitus and vascular disease","volume":"61","author":"Sowers","year":"2013","journal-title":"Hypertension"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: The bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e009890","DOI":"10.1161\/JAHA.118.009890","article-title":"Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA","volume":"7","author":"Joseph","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/01.ASN.0000132473.50966.14","article-title":"Mechanisms of Hypertension: The Expanding Role of Aldosterone","volume":"15","author":"Freel","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of Mineralocorticoid Action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/1047-2797(93)90006-P","article-title":"Risk factors for coronary heart disease mortality among persons with diabetes","volume":"3","author":"Destefano","year":"1993","journal-title":"Ann. Epidemiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: A retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/a-1507-5226","article-title":"Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test","volume":"53","author":"Voulgaris","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism. A Cross-sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients with Essential Hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/EJE-16-0003","article-title":"A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism","volume":"175","author":"Tsiavos","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-21-0625","article-title":"Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas","volume":"186","author":"Markou","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1524-6175.2005.05251.x","article-title":"The Prevalence of Primary Aldosteronism in Diabetic Patients","volume":"8","author":"Jefic","year":"2006","journal-title":"J. Clin. Hypertens."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary Aldosteronism in Diabetic Subjects with Resistant Hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1479164109350556","article-title":"Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism","volume":"7","author":"Mukherjee","year":"2010","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10641963.2012.712175","article-title":"Prevalence of Primary Aldosteronism in Hypertensive Subjects with Hyperglycemia","volume":"35","author":"Li","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cen.13370","article-title":"Prevalence of primary aldosteronism among patients with type 2 diabetes","volume":"87","author":"Tancredi","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the Prevalence of Primary Aldosteronismin Patients with New-onset Type 2 Diabetes and Hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cen.14598","article-title":"Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: A prospective study from Western India","volume":"96","author":"Memon","year":"2022","journal-title":"Clin. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/eci.12286","article-title":"Primary aldosteronism in hypertensive patients: Clinical implications and target therapy","volume":"44","author":"Papanastasiou","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1559-4564.2006.05513.x","article-title":"Prevalence of Hypertension in Type 2 Diabetes Mellitus: Impact of the Tightening Definition of High Blood Pressure and Association with Confounding Risk Factors","volume":"1","author":"Kabakov","year":"2006","journal-title":"J. Cardiometabolic Syndr."},{"key":"ref_27","first-page":"94","article-title":"Prevalence of hypertension and controlled hypertension\u2013United States. 2005\u20132008","volume":"60","author":"Keenan","year":"2011","journal-title":"MMWR Surveill Summ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","author":"Grant","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/CIRCULATIONAHA.110.008870","article-title":"Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)","volume":"124","author":"Mancia","year":"2011","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"T67","DOI":"10.1530\/JOE-17-0009","article-title":"30 years of the mineralocorticoid receptor: The role of the mineralocorticoid receptor in the vasculature","volume":"234","author":"DuPont","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/jcm4050998","article-title":"Renal Biopsy in Type 2 Diabetic Patients","volume":"4","author":"Espinel","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:32:56Z","timestamp":1760142776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["biomedicines10092308"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10092308","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}